Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC

Barchart · 04/17 15:45

Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025

Trading to be permanently suspended by Nasdaq at the open of business on April 23, 2025

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.